Deep Brain Stimulation Devices Market, By Application (Parkinson's Disease, Essential Tremor, Dystonia, and Others), by End User (Hospital & Clinics, Ambulatory Surgical Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacif

Deep Brain Stimulation Devices Market, By Application (Parkinson's Disease, Essential Tremor, Dystonia, and Others), by End User (Hospital & Clinics, Ambulatory Surgical Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Deep brain stimulation (DBS) surgery is performed as part of the treatment of various neural debilitating conditions such as Parkinson’s disease (PD), dementia, and Alzheimer’s disease. A patient fitted with a DBS device can get long-term relief from debilitating symptoms of PD. Although some patients may require medications post-surgery, there is significant reduction in side-effects caused due to medications, owing to use of DBS devices. A DBS device is mainly placed in one of the three U.S. Food and Drug Administration (FDA) approved target sites in PD. Most commonly preferred target sites are the Globus Pallidus Interna (GPi) and Subthalamic Nucleus (STN).
Market Dynamics
Approval and launch of novel and advanced DBS devices is expected to drive the global deep brain stimulation devices market growth over the forecast period. For instance, in 2017, Boston Scientific Corporation received the U.S. Food and Drug Administration for its Vercise Deep Brain Stimulation (DBS) system. Vercise DBS system is indicated for use in Parkinson’s disease treatment. DBS works by stimulating a targeted region of the brain through implanted leads that are powered by a device called an implantable pulse generator (IPG).
DBS devices are widely used in the treatment and management of diseases such as epilepsy and PD. Therefore, high prevalence of these diseases worldwide is expected to drastically increase demand for its management devices, thereby driving the global deep brain stimulation devices market growth over the forecast period. For instance, according to the data published by World Health Organization (WHO) in June 2021 epilepsy is a chronic non-communicable disease of the brain that affects people of all ages. Globally, around 50 million people suffer from epilepsy, making it one of the most common neurological diseases.
Key features of the study:
This report provides in-depth analysis of the global deep brain stimulation devices market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022 - 2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by key players
It profiles key players in the global deep brain stimulation devices market based on following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include, Boston Scientific Corporation, Medtronic, Inc., St. Jude Medical, Inc. (Abbott Laboratories), Cyberonics, Inc., Neuronetics, and Aleva Neurotherapeutics SA
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The global deep brain stimulation devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the global deep brain stimulation devices market
Detailed Segmentation:
Global Deep Brain Stimulation Devices Market, By Application:
Parkinson's Disease
Essential Tremor
Dystonia
Others
Global Deep Brain Stimulation Devices Market, By End User:
Hospital & Clinics
Ambulatory Surgical Centers
Others
Global Deep Brain Stimulation Devices Market, By Region:
North America
By Application:
Parkinson's Disease
Essential Tremor
Dystonia
Others
By End User:
Hospital & Clinics
Ambulatory Surgical Centers
Others
By Country:
U.S.
Canada
Europe
By Application:
Parkinson's Disease
Essential Tremor
Dystonia
Others
By End User:
Hospital & Clinics
Ambulatory Surgical Centers
Others
By Country:
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
By Application:
Parkinson's Disease
Essential Tremor
Dystonia
Others
By End User:
Hospital & Clinics
Ambulatory Surgical Centers
Others
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
By Application:
Parkinson's Disease
Essential Tremor
Dystonia
Others
By End User:
Hospital & Clinics
Ambulatory Surgical Centers
Others
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
By Application:
Parkinson's Disease
Essential Tremor
Dystonia
Others
By End User:
Hospital & Clinics
Ambulatory Surgical Centers
Others
By Country:
GCC
Israel
Rest of Middle East
Africa
By Application:
Parkinson's Disease
Essential Tremor
Dystonia
Others
By End User:
Hospital & Clinics
Ambulatory Surgical Centers
Others
By Country/Region:
Central Africa
South Africa
North Africa
Company Profiles
Boston Scientific Corporation*
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Medtronic, Inc.
St. Jude Medical, Inc. (Abbott Laboratories)
Cyberonics, Inc.
Neuronetics
Aleva Neurotherapeutics SA.
“*” marked represents similar segmentation in other categories in the respective section.